Track Heartbeam Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Heartbeam Inc. Common Stock BEAT · Stock Open Heartbeam Inc. Common Stock in new tab

0.3917 USD
EPS
-0.39
P/B
6.08
ROE
-328.44
Beta
-0.85
Target Price
3.13 USD
Loading chart...
Key Metrics
Earnings dateMarch 18, 2027
EPS-0.39
Book Value0.07
Price to Book6.08
% Insiders19.567%
Estimates
Forward P/E-0.75
Forward EPS-0.53
Target Mean Price3.13

DCF valuation

Model fair value for Heartbeam Inc. Common Stock (BEAT)
Result
Sign in to run the valuation for BEAT.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
2 analysts · consensus Buy · mean target 3.13 USD (low 1.25, high 5.00) · as of 15 Nov 2026
Low 1.25
Mean 3.13
High 5.00
Price 0.3917
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Heartbeam Inc. Common Stock Logo Heartbeam Inc. Common Stock Analysis (BEAT)

United States Information Technology Official Website Stock

Is Heartbeam Inc. Common Stock a good investment? Heartbeam Inc. Common Stock (BEAT) is currently trading at 0.3917 USD. Market analysts have a consensus price target of 3.13 USD. This suggests a potential upside from current levels.

Earnings Schedule: Heartbeam Inc. Common Stock is expected to release its next earnings report on March 18, 2027. The market consensus estimate for Forward EPS is -0.53.

Investor FAQ

Does Heartbeam Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Heartbeam Inc. Common Stock?

Heartbeam Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be March 18, 2027. The company currently has a trailing EPS of -0.39.

Company Profile

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.

Exchange Ticker
NMS (United States) BEAT
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion